Overall Moderator: Jong Wook KIM (Korea)
| 09:00-09:50 | Registration | |
|---|---|---|
| 09:00-09:50 | E-Poster Session (Non-moderated poster presentation) | |
|---|---|---|
| 09:50-10:00 | Opening / Welcome Remarks Jae Young JOUNG (President, the Korean Prostate Society) Sung Kyu HONG (President, Asia Pacific Society of Uro-oncology) Seong IL SEO (President, the Korean Urological Association) |
|
|---|---|---|
| Session I. Prostate Cancer I : Surgical Treatment for Localized Prostate Cancer | ||
|---|---|---|
| Time | 10:00-11:15 | |
| Chair(s) | Tag Keun YOO (Korea) Jae Young PARK (Korea) Lukman HAKIM (Indonesia) |
|
| Speaker(s) | 10:00-10:15 | RARP with da Vinci multiport: Key Steps for Nerve Sparing and Urethral Preservation — Surgical Video Tips Hisamitsu IDE (Japan) |
| 10:15-10:30 | Laparoscopic Radical Prostatectomy in 2026: Still Relevant? Tips for Precision Dissection Jong Wook PARK (Korea) |
|
| 10:30-10:45 | NeuroSAFE and Beyond: Current and Emerging Technologies for Intraoperative Surgical Margin Assessment in Radical Prostatectomy Su Jung Oh-Hohenhorst (Germany) |
|
| 10:45-10:55 | From Cognitive MRI to Real-Time Augmented Reality Overlay in RARP Se Young CHOI (Korea) |
|
| 10:55-11:15 | Case-based Panel Discussion Moderator: Seong Hyeon YU (Korea) Panel: Gyeong Eun MIN (Korea) | Yun Beom KIM (Korea) | Jong Wook PARK (Korea) Se Young CHOI (Korea) |
|
| 11:15-11:40 | Coffee Break | |
|---|---|---|
| Session II. Prostate Cancer II : Locally Advanced Prostate Cancer | ||
|---|---|---|
| Time | 11:40-12:45 | |
| Chair(s) | Seong Il SEO (Korea) U-Syn HA (Korea) Jacob See-Tong PANG (Taiwan) |
|
| Speaker(s) | 11:40-12:00 | AI in the Management of Prostate Cancer: Initial Experience from Shanghai Rui Chen (China) |
| 12:00-12:07 | Adjuvant vs. Early Salvage Radiotherapy After RP — When to Irradiate and How? Yun Sok HA (Korea) |
|
| 12:07-12:14 | Role of Extended PLND in High-risk Prostate Cancer in the PSMA PET Era Yong Hyun PARK (Korea) |
|
| 12:14-12:21 | Overtreatment vs. Undertreatment in cN1M0 Disease: Optimal Treatment Strategy Bum Sik TAE (Korea) |
|
| 12:21-12:45 | Case-based Panel Discussion Moderator: Hyun Ho HAN (Korea) Panel: Sung Dae KIM (Korea) | Won Tae KIM (Korea) | Vincent Fradet (Canada) Shian-Shiang WANG (Taiwan) | Yun Sok HA (Korea) | Yong Hyun PARK (Korea) Bum Sik TAE (Korea) |
|
| Lunch & Luncheon Symposium | ||
|---|---|---|
| Time | 12:45-13:45 | |
| Chair(s) | Jae IL CHUNG (Korea) | |
| Speaker(s) | From Clinical Evidence to Clinical Practice: Implementing PSMA Radioligand Therapy in the Real World William K. Oh (USA) |
|
| Session III. Prostate Cancer III : Focal & Ablative Therapy for Localized Prostate Cancer | ||
|---|---|---|
| Time | 13:45-14:50 | |
| Chair(s) | Moon Ki JO (Korea) Hwang Gyun JEON (Korea) |
|
| Speaker(s) | 13:45-13:52 | Follow-up After Focal Therapy: When to Re-biopsy, When to Re-treat, When to Switch Hee Jo YANG (Korea) |
| 13:52-13:59 | Who is NOT a Candidate for Focal Therapy? 2026 Guideline Consensus Sang Wook Lee (Korea) |
|
| 13:59-14:06 | Salvage Treatment after Focal Therapy Failure Hyung Joon KIM (Korea) |
|
| 14:06-14:26 | Principles of Focal Therapy in Localized Prostate Cancer: Patient Selection, Energy Sources & Follow-up Protocol Po-Hung, LIN (Taiwan) |
|
| 14:26-14:50 | Case-based Panel Discussion Moderator: Joong Won CHOI (Korea) Panel: Myung Soo KIM (Korea) | Hee Jo YANG (Korea) | Sang Wook LEE (Korea) Po-Hung, LIN (Taiwan) | Won Ik SEO (Korea) | Hyung Joon KIM (Korea) |
|
| 14:50-15:10 | Coffee Break | |
|---|---|---|
| Session IV. Prostate Cancer IV : Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | ||
|---|---|---|
| Time | 15:10-16:40 | |
| Chair(s) | Sung Kyu HONG (Korea) Jun Sung KOH (Korea) William K. Oh (USA) |
|
| Speaker(s) | 15:10-15:25 | PSMA in Prostate Cancer: From Biology to Clinical Application Naoya Nagaya (Japan) |
| 15:25-15:40 | Doublet vs. Triplet Intensification in mHSPC: Who Truly Needs More Than Two Drugs? Patient Selection Algorithm 2026 Joseph W KIM (USA) |
|
| 15:40-15:55 | Optimized Strategies in mHSPC Therapy: Balancing between Clinical Efficacy and Treatment Burden for Improving Long-term Outcomes Kuan Chou Chen (Taiwan) |
|
| 15:55-16:10 | Evidence-based Role of Radiotherapy in mHSPC Jason Chia-Hsien Cheng (Taiwan) |
|
| 16:10-16:40 | Case-based Panel Discussion Moderator: Sang Hun SONG (Korea) Panel: Soo Dong KIM (Korea) | Naoya Nagaya (Japan) | Joseph W KIM (USA) Kuan Chou Chen (Taiwan) | Jason Chia-Hsien Cheng (Taiwan) | Fumihiko URABE (Japan) |
|
| 16:40-16:50 | Day 1 Closing / Announcements | |
|---|---|---|
| 17:30-19:30 | Banquet | |
|---|---|---|
Overall Moderator: Jong Wook KIM (Korea)
| Session V. Prostate Cancer V : Emerging Biomarkers and Evolving Biopsy Strategies | ||
|---|---|---|
| Time | 09:10-10:25 | |
| Chair(s) | Choung Soo KIM (Korea) Jun Hyuk HONG (Korea) Edmund CHIONG (Singapore) |
|
| Speaker(s) | 09:10-09:30 | Liquid Biopsy in Prostate Cancer: Current Clinical Applications and Future Perspectives Fumihiko URABE (Japan) |
| 09:30-09:50 | Gut Microbiome and Prostate Cancer Vincent Fradet (Canada) |
|
| 09:50-09:57 | PSMA PET/CT after Equivocal MRI: Can We Halve Unnecessary Biopsies? (PRIMARY2 RCT) See Min CHOI (Korea) |
|
| 09:57-10:04 | Transperineal vs Transrectal Biopsy updates: TRANSLATE Trial Teak Jun SHIN (Korea) |
|
| 10:04-10:25 | Case-based Panel Discussion Moderator: Jong Soo LEE (Korea) Panel: Phil Hyun SONG (Korea) | Kyo Chul KOO (Korea) | Duc Minh PHAM (Vietnam) See Min CHOI (Korea) | Teak Jun SHIN (Korea) |
|
| 10:25-10:50 | Coffee Break | |
|---|---|---|
| Session VI. Urothelial Cancer : NMIBC, MIBC & UTUC — Novel Therapies & Precision Medicine | ||
|---|---|---|
| Time | 10:50-11:55 | |
| Chair(s) | Byong Chang JEONG (Korea) Seok Ho KANG (Korea) Teng Aik ONG (Malaysia) |
|
| Speaker(s) | 10:50-11:10 | UTUC & Synchronous Bladder Cancer: Staging, Sequencing & Treatment Strategies - Taiwan Experience Shian-Shiang WANG (Taiwan) |
| 11:10-11:17 | FGFR-targeted Therapy in NMIBC: Intravesical Erdafitinib (TAR-210) & Oral Dabogratinib (SURF302) Tae Young PARK (Korea) |
|
| 11:17-11:24 | Neoadjuvant & Perioperative Therapy for MIBC: EV+Pembrolizumab (KEYNOTE-B15) & NIAGARA (Durvalumab+GemCis) Se Yun KWON (Korea) |
|
| 11:24-11:31 | Bladder Preservation After NAC in MIBC: Cystectomy vs. Organ-sparing Approaches Jong Kil NAM (Korea) |
|
| 11:31-11:55 | Case-based Panel Discussion Moderator: Sung Goo YOON (Korea) Panel: Jung Ki JO (Korea) | Hyun Young LEE (Korea) | Lukman HAKIM (Indonesia) Po-Hung, LIN (Taiwan) | Tae Young PARK (Korea) | Se Yun KWON (Korea) | Jong Kil NAM (Korea) |
|
| 11:55-12:10 | KPS BLUE Award Jae Young JOUNG (President, the Korean Prostate Society) |
|
|---|---|---|
| Lunch / Luncheon Symposium | ||
|---|---|---|
| Time | 12:10-13:20 | |
| Chair(s) | Kyung Seop LEE (Korea) | |
| Speaker(s) | 12:10- | Navigating mHSPC: Clinical evidence supporting the efficacy of Apalutamide Se Young CHOI (Korea) |
| Session VII. Prostate Cancer VI : Metastatic Castration-Resistant Prostate Cancer (mCRPC) | ||
|---|---|---|
| Time | 13:20-14:40 | |
| Chair(s) | Taek Won KANG (Korea) Jae Seung CHUNG (Korea) Kuan Chou Chen (Taiwan) |
|
| Speaker(s) | 13:20-13:40 | Current status and challenges in mCRPC treatment Hiroji UEMURA (Japan) |
| 13:40-14:00 | Can We Predict Treatment Response in Prostate Cancer? Patient-derived Organoids & Treatment Response Prediction Su Jung Oh-Hohenhorst (Germany) |
|
| 14:00-14:20 | Emerging Therapies in mCRPC: T Cell Engagers, ADCs and Bifunctional Proteins Joseph W KIM (USA) |
|
| 14:20-14:40 | Case-based Panel Discussion Moderator: Dong Ho SHIN (Korea) Panel: Sang Chul LEE (Korea) | Won Hoon SONG (Korea) | Edmund CHIONG (Singapore) Hisamitsu IDE (Japan) | Hiroji UEMURA (Japan) | Su Jung Oh-Hohenhorst (Germany) Joseph W KIM (USA) |
|
| Satellite symposium | ||
|---|---|---|
| Time | 14:40-15:00 | |
| Chair(s) | Seok Joong YUN (Korea) | |
| Speaker(s) | 14:40-15:00 | The New Treatment Option for Male LUTS: Vesomni Jae Heon KIM (Korea) |
| 15:00-15:20 | Coffee Break | |
|---|---|---|
| Session VIII. Surgical Treatment of Benign Prostatic Hyperplasia (BPH) : Laser Surgery, Minimally Invasive Techniques & Postoperative Management | ||
|---|---|---|
| Time | 15:20-16:30 | |
| Chair(s) | Tae Hyo KIM (Korea) Jong Wook PARK (Korea) |
|
| Speaker(s) | 15:20-15:35 | Beyond the Standard: Shaping the New Era of BPH Surgery with MIST (UroLIFT, Rezum, iTind) Ji Hoon AHN (Korea) |
| 15:35-15:50 | HoLEP in 2026: Who Should Still Be Doing It and How to Optimize Results Chung Lyul LEE (Korea) |
|
| 15:50-16:05 | Robot Simple Prostatectomy - Approach, Urethral Reconstruction & Outcomes in Large Glands Tae Yong PARK (Korea) |
|
| 16:05-16:12 | Post-operative Voiding Dysfunction and Detrusor Underactivity after BPH Surgery Ho Young RYU (Korea) |
|
| 16:12-16:30 | Case-based Panel Discussion Moderator: Jae Hyun RYU (Korea) Panel: Hong Zoo PARK (Korea) | Teng Aik ONG (Malaysia) | Ji Hoon AHN (Korea) Chung Lyul LEE (Korea) | Tae Yong PARK (Korea) | Ho Young RYU (Korea) |
|
| 16:30-17:00 | Best Abstract Prize Ceremony & Closing Remarks Jae Young JOUNG (President, the Korean Prostate Society) |
|
|---|---|---|
| 17:00 | Banquet | |
|---|---|---|
Copyright(C) by 2026 KPS in conjunction with APSU Joint International Symposium.
All rights reserved.
Secretariat of KPS
Gaon Convention Services, Inc.
ADDRESS: ROOM 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989 | E-MAIL : gaonpco@gaonpco.com
* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.